AI Terminal

MODULE: AI_ANALYST
Interactive Q&A, Risk Assessment, Summarization
MODULE: DATA_EXTRACT
Excel Export, XBRL Parsing, Table Digitization
MODULE: PEER_COMP
Sector Benchmarking, Sentiment Analysis
SYSTEM ACCESS LOCKED
Authenticate / Register Log In

Oxford Instruments PLC

M&A Activity May 1, 2015

4677_rns_2015-05-01_017de1d7-2d68-417b-a442-b5c64bbe2d5b.html

M&A Activity

Open in Viewer

Opens in native device viewer

National Storage Mechanism | Additional information

You don't have Javascript enabled. For full functionality this page requires javascript to be enabled.

RNS Number : 9497L

Oxford Instruments PLC

01 May 2015

Release date: 1 May 2015

Oxford Instruments plc

Acquisition of Medical Imaging Resources, Inc.

Oxford Instruments plc, a leading provider of high technology tools and systems for industry and research, today announces the acquisition of Medical Imaging Resources, Inc. (MIR).

Founded in 1990 in Ann Arbor Michigan by CEO John Vartanian, MIR specialises in the build, lease and service of mobile medical imaging labs ("mobiles").

The mobile labs are built in MIR's factory, with Magnetic Resonance Imaging (MRI) and Computed Tomography (CT) systems from Siemens, GE, Philips and Toshiba.  These are leased to customers across the USA.  MIR is also responsible for servicing its mobiles.  Customers include hospitals and clinics that need additional capacity or that wish to trial MRI or CT machines without committing to the infrastructure and cost associated with a permanent unit.   

MIR will form a part of OIHealthcare, within the Group's Service sector, which already services GE MRI and CT machines in the USA.  There are a number of synergies with OIHealthcare:

·     This will be a significant step to making OIHealthcare a multi-skilled independent service provider able to support large individual service contracts;

·     Access to OIHealthcare's parts and its purchasing power for complete systems will lower MIR's operating costs;

·     There will be overheads savings in those areas where duplication is eliminated;

·     MIR currently sub-contracts a significant portion of the service work for its mobiles.  OIHealthcare staff are located in numerous states and once trained will take over the work and will be able to bring the margin in-house.

Consideration, which will be satisfied from existing facilities, comprises $10.4 million (c. £6.8 million) on completion followed by a further $10.1 million (c. £6.6 million) earn-out payable one year later. MIR has approximately $3.0 million (c. £2.0 million) net debt at completion.

In the year to 31 December 2014, MIR had sales of $16.6 million (c. £10.8 million), profit before tax of $2.8 million (c. £1.8 million) and EBITDA of $5.6 million (c. £3.6 million).  At 31 December 2014, MIR had gross assets of $9.4 million (c. £6.1 million).

Jonathan Flint (Chief Executive) and Kevin Boyd (Finance Director) will host a conference call for analysts and investors on this announcement at 9:30 am (UK time), today 1 May.  To join the call, please use the dial-in numbers below:

Dial:   +44 (0)20 3139 4830

PIN:    89662683# 

- Ends -

Enquiries:

Oxford Instruments plc                                       Tel: 01865 393200

Jonathan Flint, Chief Executive

Kevin Boyd, Group Finance Director

MHP                                                                     Tel: 020 3128 8100

Rachel Hirst / Jack Holden

Issued for and on behalf of Oxford Instruments plc

Notes to Editors  

About Oxford Instruments plc

Oxford Instruments designs, supplies and supports high-technology tools and systems with a focus on research and industrial applications. Innovation has been the driving force behind Oxford Instruments' growth and success for over 50 years, and its strategy is to effect the successful commercialisation of these ideas by bringing them to market in a timely and customer-focused fashion.

The first technology business to be spun out from Oxford University, Oxford Instruments objective is to be the leading provider of new generation tools and systems for the research and industrial sectors with a focus on nanotechnology. Its key market sectors include nano-fabrication and nano-materials. The company's strategy is to expand the business into the life sciences arena, where nanotechnology and biotechnology intersect.

This involves the combination of core technologies in areas such as low temperature, high magnetic field and ultra high vacuum environments; Nuclear Magnetic Resonance; x-ray, electron, laser and optical based metrology; atomic force microscopy; optical imaging; advanced growth, deposition and etching.

Oxford Instruments aims to pursue responsible development and deeper understanding of our world through science and technology. Its products, expertise, and ideas address global issues such as energy, environment, security and health.

This information is provided by RNS

The company news service from the London Stock Exchange

END

ACQEAFLEDSDSEAF

Talk to a Data Expert

Have a question? We'll get back to you promptly.